Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EurasiaBIO is a Eurasian technology platform dedicated to the advancement of the biotechnology industry and bioeconomy within the Eurasian Economic Union (EAEU). It functions as a strategic consortium that bridges the gap between scientific research, industrial application, and government policy to foster innovation in biopharmaceuticals, agriculture, and industrial biotech. The organization coordinates large-scale R&D projects, facilitates technology transfer, and works to harmonize regulatory standards across member states. By integrating the resources of universities, research institutes, and private enterprises, EurasiaBIO aims to enhance the global competitiveness of the Eurasian biotech sector. Its activities include supporting the development of new medicines, bio-based materials, and sustainable agricultural solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eurasian Technology Platform EurasiaBIO.